Skip to main content
. 2007 Jun 21;8(3):384–392. doi: 10.1007/s10162-007-0085-8

TABLE 1.

Subject characteristics

Subject Age (yrs) Duration of hearing loss (yrs)a Duration of implant use (yrs) Etiology Implant type Speech processor strategy CNC word score(% correct)
S01 61 0.3 2 Unknown Nucleus 24 ACE 92
S02 69 3 8 Unknown Nucleus 24 ACE 42
S03 61 5 11 Genetic Nucleus 22 SPEAK
S04 62 1 3 Unknown Nucleus 24 ACE 88
S09 41 0.5 0.5 Head trauma HiRes90K HiRes 40
S10 76 5 0.3 Otosclerosis HiRes90K HiRes 50
S11 41 0 4.5 Prenatal rubella Clarion CII HiRes
S12 49 0 2 Connexin 26 MedEl Combi40+ CIS
S14 46 10 1 Unknown Nucleus 22 ACE
S16 50 17 1 Unknown HiRes90K HiRes 46
S17 55 19 7 Unknown Nucleus 24 ACE
S18 74 6 Sudden hearing loss Nucleus 24 ACE 52
S19 63 12 3 Genetic Nucleus24 ACE 88
S20 53 10 2 Unknown Nucleus24 ACE 80
S21 59 8 6 Otosclerosis (L)Nucleus24; (R) Nucleus24 ACE 90
S22 70 8 6 Unknown Nucleus24 ACE 80
S23 60 15 7 Unknown Nucleus24 ACE 56
S24 41 4 2 Hereditary Nucleus24 ACE 82
S25 43 2 1.7 Radiation Nucleus 24 ACE 80
S26 55 11 4 Unknown Nucleus 24 ACE 62
S27 50 24 4 Hereditary Nucleus 24 ACE 78
S28 44 2 3 Cogan's Syndrome (L) Nucleus 22; (R) Nucleus 22 ACE 100
S29 68 10 5 Otosclerosis (L) Nucleus 24;(R)Nucleus22 (L)ACE; (R)SPEAK 58
S30 66 5 3.5 Amikacin (L)Nucleus Freedom; (R)Nucleus 22 ACE 80
S31 55 1 1 Hereditary Nucleus Freedom ACE 90
S32 57 57 3 Sensorineural at birth (L)Nucleus 24; (R)Nucleus Freedom ACE 52
S33 57 15 16 Unknown (L)Nucleus 24; (R)Nucleus 22 (L)CIS; (R)SPEAK 70
S34 55 1.5 Noise exposure HiRes90K HiRes 62
S35 72 3 2 Unknown Nucleus 24 ACE 70
S37 81 3 2.5 Unknown Nucleus 24 ACE 24
S38 51 9 4 Noise-induced and ototoxicity Nucleus 24 ACE 100

aThe duration of their hearing loss before implantation